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INTRODUCTION
Transscleral cyclo-photocoagulation (TSCPC) is a cyclo-de-
structive procedure. It targets the secretory epithelium of the 
ciliary epithelium, which subsequently causes a reduction in 
the aqueous humour production and lowers the intraocular 
pressure (IOP). It is a semi-conductor solid-state diode laser 
system (810 nm wavelength) with a handpiece that is used 
to deliver laser energy.1 TSCPC is usually reserved for man-
aging uncontrolled intraocular pressure (IOP) in eyes with 
poor visual potential.2 It is beneficial for pain relief in a blind 
glaucomatous eye3,4, refractory glaucoma5,6, secondary and 
complex glaucoma patients7 or patients who refused invasive 
surgery. Some chose conventional trabeculectomy with or 
without cataract surgery to control IOP.8 Nevertheless, criti-
cal eye care is important for post-surgery quality.9
Both short and long duration has been postulated to be ef-
fective in lowering the IOP. Standard, 2000ms short duration 
was applied for dark iris colour with power titrated accord-
ing to occasional ‘pop’.10 Meanwhile, the no-pop technique 
or better known as slow coagulation described by Gaaster-
land is to use the longer duration of 4000ms in brown iris 
colour patient.11 Some studies suggested that longer duration 
of TSCPC is more effective compared to shorter duration of 
TSCPC, especially in the eye with more pigment.11,12 The ra-
tionale behind is longer burns and lower power help reduc-
ing tissue destruction and inflammation outside the ciliary 
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ABSTRACT
Introduction: Transscleral cyclo-photocoagulation (TSCPC) is a cyclo-destructive procedure which targets the secretory epithe-
lium of the ciliary epithelium and applicable to reduce intraocular pressure. 
Objective: To compare the outcomes of transscleral diode cyclo-photocoagulation using short-duration (SD) versus long-dura-
tion (LD) burn treatment in ASEAN brown iris patients. 
Methods: We analysed retrospective data from twenty-five eyes with glaucoma cases of any type who underwent cyclo-photo-
coagulation with SD (2000 ms) with variable power of ≤2000 mW versus LD (4000 ms) treatment with variable power ≤1200mW. 
The intraocular pressure (IOP) and the number of antiglaucoma eyedrops reduction, visual acuity changes, and complications 
between the two techniques were documented. 
Results: The mean  IOP before treatment was 47.2 (8.4) mmHg and 30.15 (7.7) mmHg for SD and LD group respectively. At the 
final visit post-treatment, there was a reduction of IOP in both groups having 28.0 mmHg in SD (p>0.05) and 22.15 mmHg in the 
LD (p<0.05), respectively from pre-treatment. The mean number of eye drops before treatment was 3.6 for the SD group and 3.9 
for the LD group. Post-treatment, it dropped to 1.4 for SD group (p>0.05) and 1.8 for the LD group (p>0.05). The mean logMAR 
visual acuity before treatment was 2.46 (SD)  and 2.10 (LD) and at the post-treatment, the mean logMAR was 2.70 (SD)  and 
2.10 (LD) (p>0.05). Both treatments resulted in complications such as inflammation, hypotony and hyphaema. 
Conclusion: Both treatments reduced the intraocular pressure, and the number of antiglaucoma eye drops needed in ASEAN 
brown iris glaucoma patient. Comparatively, complications such as inflammation, hypotony and hyphaema were more in the LD 
group. 
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